Amelogenesis Imperfecta

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-11-30

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Amelogenesis Imperfecta (AI) are a heterogeneous group of rare genetic diseases transmitted according to various mode of inheritance (X-linked, autosomal dominant, autosomal recessive) affecting the formation/mineralization of tooth enamel. These diseases exist in isolation with clinical manifestations limited to the oral cavity or may be associated to other symptoms in syndromes. Many different genes (AMELX, ENAM, ENAMELYSIN or MMP20, KLK4, DLX3, FAM83H, FAM20A WDR72…) coding for enamel matrix proteins, enamel matrix degrading proteins, proteins involved in hydroxyapatite formation and growth and mineralization processes have been discovered responsible for the clinical phenotypes (hypoplastic, hypomineralized, hypomature) encountered in AI.

Genes involved in enamel formation but not yet identified in association with any form of AI include: AMELY, AMELOBLASTIN, TUFTELIN, AMELOTIN, A Pin protein, ODAM (Odontogenic ameloblast associated).

In this research protocol the investigators explore the phenotype including the enamel ultrastructure and the genotype of a cohort of patients presenting AI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Orodental Manifestations of Rare Diseases

NCT02397824

Rare Disease Orodontal

RECRUITING

Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease

NCT00250146

Celiac Disease

TERMINATED NA

SCREENING OF CELIAC DISEASE IN SCHOLAR CHILDREN IN ITALY

NCT04867863

Celiac Disease Dental Caries

COMPLETED

Treatment of Screen-detected Celiac Disease

NCT01116505

Celiac Disease

COMPLETED NA

Nutritional Intake and Bone Health in Celiac Disease

NCT03364556

Celiac Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amelogenesis Imperfecta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amelogenesis Imperfecta

Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth

Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth.

Intervention Type GENETIC

healthy family members

Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth

Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth.

Intervention Type GENETIC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth.

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient presenting with AI
* New patient or patient already known in the center
* Child (in his primary dentition) or adult
* Man or woman
* Having signed a consent form or accepted to participate to the study
* Patient affiliated to social security
* Validation of the inclusion by the principal investigator looking at the patient file

Exclusion Criteria

* Patient with acquired enamel defects
* Patient whose clinical diagnostic is not possible
* Patient whose clinical file does not contain teeth photos
* Patient who has not signed a consent form and accepted to participate to the study
* Patient who is not affiliated to social security.
* Non validation of the inclusion by the principal investigator looking at the patient file

Eligible Sex

ALL

Accepts Healthy Volunteers

No